The Health 2.0 grassroot movement is the perfect opportunity for the pharma industry to reinvent itself, go beyond their mission to develop and market new drugs, and be part of a more global and patient-centric approach to health care. This session not only explores tools producing data that fuel R&D but also showcases solutions that allow the pharma industry to further engage with patients and strengthen their collaboration with doctors.

Indu Subaiya delivers her keynote “Is Digital Health Becoming its Own Industry?” at the 9th Annual Health 2.0 Conference.

Featured speaker Chelsea Clinton, Vice Chair of the Clinton Foundation, speaks at the 9th Annual Health 2.0 Fall Conference.

iHealth Labs Europe discussed the practical development of new health care devices as well as the pitfalls to avoid for new health care products. Having an idea is easy, it’s how you put it in practice that is important.

After years contributing to the digital health investment landscape, Vishal Gulati, Venture Partner at DFJ Esprit, examined the biggest lies and best kept secrets about VC funding in Europe.

Younghee Ro, the international representative of Wellness IT Association, discussed the Happiness Platform.

Alongside the NHS, Health 2.0 explored how public health players can create a new landscape for interoperability by leveraging a system built on open source.

Homero Rivas is an Assistant Professor of Surgery, and the Director of Innovative Surgery at Stanford University. He has been involved in mHealth for many years, Co-Founding multiple digital health companies, and advising to many startups. As a Glass Explorer from Google, he has organized several research projects using Glass and other wearables to improve safety in the operating room. At Health 2.0 Barcelona, Homero shared his perspective on integrating digital health tools into his practice and how providers are increasingly contributing to the patient safety movement.